Luciani Alain, Vignaud Alexandre, Cavet Madeleine, Nhieu Jeanne Tran Van, Mallat Ariane, Ruel Lucile, Laurent Alexis, Deux Jean-François, Brugieres Pierre, Rahmouni Alain
INSERM Unite U 841, Equipe 17, Molecular Mechanisms of Liver Fibrosis, Creteil, France.
Radiology. 2008 Dec;249(3):891-9. doi: 10.1148/radiol.2493080080.
To retrospectively evaluate a respiratory-triggered diffusion-weighted (DW) magnetic resonance (MR) imaging sequence combined with parallel acquisition to allow the calculation of pure molecular-based (D) and perfusion-related (D*, f) diffusion parameters, on the basis of the intravoxel incoherent motion (IVIM) theory, to determine if these parameters differ between patients with cirrhosis and patients without liver fibrosis.
The institutional review board approved this retrospective study; informed consent was waived. IVIM DW imaging was tested on three alkane phantoms, on which the signal-intensity decay curves according to b factors were logarithmically plotted. Ten b factors (0, 10, 20, 30, 50, 80, 100, 200, 400, 800 sec/mm(2)) were used in patients. Patients with documented liver cirrhosis (cirrhotic liver group, n = 12) and patients without chronic liver disease (healthy liver group, n = 25) were included. The mean liver D, D*, and f values were measured and compared with the apparent diffusion coefficient (ADC) computed by using four b values (0, 200, 400, 800 sec/mm(2)). Liver ADC and D, f, and D* parameters were compared between the cirrhotic liver group and healthy liver group. Means were compared by using the Student t test.
Signal-intensity decay curves were monoexponential on phantoms and biexponential in patients. In vivo, mean ADC values were significantly higher than D in the healthy liver group (ADC = 1.39 x 10(-3) mm(2)/sec +/- 0.2 [standard deviation] vs D = 1.10 x 10(-3) mm(2)/sec +/- 0.7) and in the cirrhotic liver group (ADC = 1.23 x 10(-3) mm(2)/sec +/- 0.4 vs D = 1.19 x 10(-3) mm(2)/sec +/- 0.5) (P = .03). ADC and D* were significantly reduced in the cirrhotic liver group compared with those in the healthy liver group (respective P values of .03 and .008).
Restricted diffusion observed in patients with cirrhosis may be related to D* variations, which reflect decreased perfusion, as well as alterations in pure molecular water diffusion in cirrhotic livers.
回顾性评估一种呼吸触发的扩散加权(DW)磁共振(MR)成像序列结合并行采集技术,以根据体素内不相干运动(IVIM)理论计算基于纯分子的(D)和灌注相关的(D*,f)扩散参数,确定这些参数在肝硬化患者和无肝纤维化患者之间是否存在差异。
机构审查委员会批准了这项回顾性研究;豁免了知情同意。在三个烷烃模型上测试了IVIM DW成像,并根据b因子对数绘制了信号强度衰减曲线。患者使用了10个b因子(0、10、20、30、50、80、100、200、400、800秒/毫米²)。纳入有肝硬化记录的患者(肝硬化肝脏组,n = 12)和无慢性肝病的患者(健康肝脏组,n = 25)。测量肝脏的平均D、D和f值,并与使用四个b值(0、200、400、800秒/毫米²)计算的表观扩散系数(ADC)进行比较。比较肝硬化肝脏组和健康肝脏组之间的肝脏ADC以及D、f和D参数。采用Student t检验比较均值。
模型上的信号强度衰减曲线为单指数曲线,而患者体内为双指数曲线。在体内,健康肝脏组的平均ADC值显著高于D值(ADC = 1.39×10⁻³毫米²/秒±0.2[标准差],而D = 1.10×10⁻³毫米²/秒±0.7),肝硬化肝脏组也是如此(ADC = 1.23×10⁻³毫米²/秒±0.4,而D = 1.19×10⁻³毫米²/秒±0.5)(P = 0.03)。与健康肝脏组相比,肝硬化肝脏组的ADC和D*显著降低(各自的P值为0.03和0.008)。
肝硬化患者中观察到的扩散受限可能与D变化有关,D变化反映灌注减少,以及肝硬化肝脏中纯分子水扩散的改变。